1. Home
  2. SVM vs KLRA Comparison

SVM vs KLRA Comparison

Compare SVM & KLRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silvercorp Metals Inc.

SVM

Silvercorp Metals Inc.

N/A

Current Price

$7.26

Market Cap

2.1B

ML Signal

N/A

Logo Kailera Therapeutics Inc. Common Stock

KLRA

Kailera Therapeutics Inc. Common Stock

N/A

Current Price

$11.57

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SVM
KLRA
Founded
2003
2024
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.7B
IPO Year
2005
2026

Fundamental Metrics

Financial Performance
Metric
SVM
KLRA
Price
$7.26
$11.57
Analyst Decision
Buy
Strong Buy
Analyst Count
6
7
Target Price
$14.25
★ $43.00
AVG Volume (30 Days)
★ 2.6M
780.6K
Earning Date
11-05-2026
11-04-2026
Dividend Yield
★ 0.33%
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$3.19
N/A
Revenue Next Year
$69.05
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.11
$9.76
52 Week High
$15.77
$23.82

Technical Indicators

Market Signals
Indicator
SVM
KLRA
Relative Strength Index (RSI) 32.11 40.01
Support Level N/A $9.76
Resistance Level $10.02 $11.81
Average True Range (ATR) 0.48 1.01
MACD -0.06 -0.18
Stochastic Oscillator 2.28 5.26

Price Performance

Historical Comparison
SVM
KLRA

About SVM Silvercorp Metals Inc.

Silvercorp Metals Inc is engaged in the acquisition, exploration, development, and mining of mineral properties. The Company's producing mines are located in China, and current exploration and development projects are located in China, Ecuador and Kyrgyz Republic. The company operates in single segment. The Company mainly produces and sells silver, lead, zinc, gold and other metals. The company's producing projects are Ying Mining District, GC Mine; construction projects are El Domo; permitting project is BYP Mine; development project includes Condor, Tulkubash/Kyzyltash.

About KLRA Kailera Therapeutics Inc. Common Stock

Kailera Therapeutics Inc is a clinical-stage biotechnology company. The company focuses on developing a diversified pipeline to provide options for people living with obesity. The company is progressing four clinical-stage product candidates, leveraging multiple GLP-1 based mechanisms of action and routes of administration. The company's obesity-first approach seeks to advance product candidates with the potential to maximize weight loss and address critical needs in the current therapeutic landscape.

Share on Social Networks: